Geode Capital Management LLC Acquires 28,252 Shares of 23andMe Holding Co. (NASDAQ:ME)

Geode Capital Management LLC increased its holdings in 23andMe Holding Co. (NASDAQ:ME) by 0.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,246,093 shares of the company’s stock after acquiring an additional 28,252 shares during the period. Geode Capital Management LLC owned about 17.32% of 23andMe worth $1,476,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of ME. Vanguard Personalized Indexing Management LLC boosted its holdings in shares of 23andMe by 410.4% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 88,555 shares of the company’s stock worth $35,000 after acquiring an additional 71,204 shares during the period. Point72 DIFC Ltd bought a new position in shares of 23andMe in the second quarter worth $43,000. Levin Capital Strategies L.P. bought a new position in shares of 23andMe in the second quarter worth $61,000. AQR Capital Management LLC boosted its holdings in shares of 23andMe by 145.8% in the second quarter. AQR Capital Management LLC now owns 444,222 shares of the company’s stock worth $174,000 after acquiring an additional 263,468 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. bought a new position in shares of 23andMe in the second quarter worth $203,000. 36.10% of the stock is owned by institutional investors.

23andMe Price Performance

23andMe stock opened at $3.84 on Friday. 23andMe Holding Co. has a one year low of $2.65 and a one year high of $16.52. The firm has a market capitalization of $100.29 million, a P/E ratio of -0.15 and a beta of 1.14. The business has a fifty day moving average price of $3.62 and a 200-day moving average price of $5.83.

23andMe (NASDAQ:ME) last issued its quarterly earnings data on Tuesday, November 12th. The company reported ($2.32) earnings per share (EPS) for the quarter. 23andMe had a negative return on equity of 129.98% and a negative net margin of 318.39%. The business had revenue of $44.07 million during the quarter, compared to analysts’ expectations of $50.30 million.

About 23andMe

23andMe Holding Co operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications.